Trial intelligence / Profile preview

Pentoxifylline for reducing proteinuria in type 2 diabetes

IRCT2016111827097N2Phase 2Completed

Sponsor
Ardabil University of Medical Sciences
Start
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of pentoxifylline in type 2 diabetes mellitus (T2DM) and proteinuria, sponsored by Ardabil University of Medical Sciences. Started Nov 2016; status: completed.

02

Drugs

pentoxifylline
03

Conditions

type 2 diabetes mellitus (T2DM)proteinuria

Beyond the preview

Go deeper on IRCT2016111827097N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016111827097N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call